HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Additional FDA funds

This article was originally published in The Rose Sheet

Executive Summary

FDA receives $150 million in additional funding for fiscal 2008 in the Supplemental Appropriations Bill of 2008, H.R. 2642, signed June 30 by President Bush. The appropriation includes $66.8 million for the Center for Food Safety and Applied Nutrition, which houses the Office of Colors and Cosmetics, $28 million for the Center for Drug Evaluation and Research and $12.7 million for the Center of Biologics Evaluation and Research. In an effort led by Pennsylvania Republican Arlen Specter, the Senate initially approved giving FDA $275 million in additional fiscal 2008 funding, but the administration vowed to veto those elevated spending levels. FDA received a $1 million increase dedicated to cosmetics oversight in fiscal 2008 in an omnibus bill passed in January (1"The Rose Sheet" Jan. 7, 2008, p. 5). House appropriators now are looking for progress on fiscal 2009 appropriations despite partisan differences (see 2related story)...
Advertisement

Related Content

Fiscal 2009 Spending Bill Will Likely Need to Wait For Next Administration
FDA Gets $1 Million Increase For Cosmetics Oversight In Fiscal 2008
FDA Gets $1 Million Increase For Cosmetics Oversight In Fiscal 2008
Advertisement
UsernamePublicRestriction

Register

RS015517

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel